Feeding Cats With Chronic Kidney Disease: Customizing the Nutritional Management Plan
The approach to nutritional management of chronic kidney disease (CKD) in cats has changed significantly over the past 2 decades. In the past, cats typically were diagnosed as having late-stage kidney “failure,” or what would now be classified as International Renal Interest Society (IRIS; iris-kidney.com) later stage 3 or stage 4, when clinical signs such as anorexia, lethargy, and weight loss raised concerns on the part of the cat owner. After diagnosis, veterinarians prescribed one of a limited number of reduced-protein therapeutic renal diets that inappetent or ill patients often refused. The clinical picture tended to deteriorate quickly, resulting in poor quality of life for the patient and anxiety for the owner.
Today the outlook is significantly improved for both cats and owners. Proactive preventive care, monitoring, and screening, coupled with heightened awareness of feline CKD prevalence, have enabled veterinarians to diagnose CKD earlier—frequently in IRIS stages 1 and 2, before cats have begun to demonstrate clinical signs of disease. This, in turn, has facilitated early nutritional intervention and a stepwise approach to CKD management. With diligent monitoring and individualized management, there is opportunity not only to slow the disease progression but to sustain a good quality of life for many years.
This article, the second in a 2-part series on feline CKD,1 addresses nutritional intervention, which is the cornerstone for maintaining health and quality of life for cats with CKD. Rather than resorting to the one-size-fits-all dietary approaches of the past, veterinarians today can manage patients as the unique individuals they are when making nutritional recommendations. Overall, the goals of nutritional management of CKD are as follows:2 (1) improve or prevent consequences of CKD and uremia; (2) slow progression and/or prolong survival; (3) minimize imbalances of electrolyte, mineral, and acid-base balance; and (4) maintain adequate nutrition.
NUTRITIONAL ASSESSMENT FOLLOWING CKD DIAGNOSIS
- Thorough diet history, including current diet and intake. What is the cat currently eating (TABLE 1), including treats and food used to give medication? Has appetite or intake changed? Is the cat eating enough of its current diet to assure sufficient consumption of specific nutrients and calories?
- Complete physical exam, including body weight and body (BCS) and muscle condition scores (MCS). Is the patient’s BCS ideal, underweight, or overweight? Has the cat lost weight or remained weight-stable since its last exam? Does the MCS assessment reveal mild, age-related sarcopenia or has muscle loss accelerated?
- Hydration status. Is the cat dehydrated? Have changes in urine output been noted?
- Comorbidities. Does the patient have a concurrent condition, such as hyperthyroidism, hypertension, obesity, or impaired gastrointestinal function?
Assessing the nutritional status, the stage of disease, and the patient’s overall state of health can help guide the veterinarian’s nutritional recommendation to meet the needs of the individual cat.
When conducting a nutritional assessment, it is important to gain a comprehensive understanding of everything the cat is eating daily, while also analyzing the nutritional profile of the diet.
A STEP-WISE APPROACH TO NUTRITIONAL MANAGEMENT
The advent of new strategies to diagnose CKD earlier also makes it possible to intervene earlier with nutrition. However, clinical research is less clear regarding when or what nutritional therapy should be implemented in early stages of CKD. Few nutrients aside from phosphorus have been studied in isolation or at early stages of disease. Clinical trials have resulted in recommendations based instead on overall “diet effect,” especially in IRIS stages 3 and 4.
The following are prioritized nutritional goals for cats diagnosed with early CKD:
- Promote and increase water intake, transitioning to all or part canned food if necessary.
- Make diet changes gradually to increase acceptance.
- Meet individual calorie needs to maintain healthy, stable weight.
- Select a product that provides high-quality protein to meet the cat’s needs (approximately 5 g/kg body weight)4 yet avoid excessive levels.
- Reduce dietary phosphorus.
- Ensure that more than 90% of calories consumed are from a therapeutic diet formulated to meet the cat’s needs and that foods used for treats or medication administration don’t exceed 10% of caloric intake, provide excess nutrients, or create nutrient imbalances.
The Obesity Paradox: A Cushion Against Mortality?
Obesity can be a complex issue to manage in cats with early CKD. On the one hand, obesity contributes to such conditions as osteoarthritis, diabetes, and urinary tract disease. On the other hand, excessive weight loss in feline patients with CKD can lower survival rate.10
Given high rates of both obesity and CKD in cats, it is inevitable that clinicians must weigh the relative risks and benefits of a weight reduction program in certain patients. The following steps are recommended:
- Perform a BCS on every patient at every visit and review the diet history. This reveals trends over time, both before and after CKD diagnosis.
- If the patient is 30% or more above ideal body weight, institute a judicious weight-loss program. If the patient is only mildly overweight (e.g., 6 or 6.5 on a 9-point BCS scale), feeding for stability vs. weight loss is preferable.
- When instituting a weight-loss program, restrict calories but do not restrict protein to avoid loss of lean muscle mass. Switching to a protein-restricted, energy-dense diet in the early stages of CKD is especially problematic because it can lead to concurrent body fat gain/muscle loss.
Among nutritional recommendations, the most controversial may be that for protein. Historically, veterinarians were taught to reduce dietary protein upon diagnosing CKD, but that long-held assumption is changing. Without evidence that dietary protein reduction slows progression, the goal should be to feed a level of protein that meets the cat’s needs while minimizing phosphorus. Dietary management alone will not prevent or reverse sarcopenia or cachexia, but calorie and/or protein deficiencies will certainly worsen it.5 Weight loss in cats with CKD is associated with a lower survival rate,10 which supports the importance of assuring adequate calories and protein intake in addition to phosphorus restriction. The introduction of newer therapeutic diets allows for customization of dietary recommendations for early- and late-stage CKD patients.
ADVANCED CKD: WHEN FEEDING NEEDS AN ASSIST
Assuring hydration and food intake is one of the most important components of nutritional management of cats with CKD. The goal when recommending a specific food and dose is to maintain stable, healthy body weight. Monitoring kidney function, hydration, body weight, BCS, and MCS is key to catching any decline quickly. If cats are unable to maintain weight on their own, intervention is essential.
If the cat’s intake has waned, the first approach is to minimize nausea and/or increase the palatability of the diet. If substituting food flavors, textures, or serving temperatures does not improve intake, an antiemetic or appetite stimulant can be considered. Mirtazapine has been proven to significantly increase appetite, reduce vomiting, and promote weight gain in cats with CKD11 and can be administered orally or as a transdermal ointment.
If an appetite stimulant does not yield the desired results of intake equal to the daily caloric requirement, then nutritional support by a long-term feeding tube should be considered. Either an esophagostomy tube or gastrostomy tube feeding is a very effective and a convenient way to provide food, water and liquid medications to cats with CKD.12 This can also eliminate the need for administering subcutaneous fluids, which contain sodium.
Nutritional management of cats with CKD can positively affect the course of disease as well as quality of life for patients. With early diagnosis, veterinarians have the opportunity to intervene nutritionally throughout the disease process, basing their recommendations on the individual and changing needs of the whole cat, not just its kidneys. By recommending a diet that meets the individual patient’s needs and supports stable body weight while minimizing the risks of disease progression, the veterinarian can make a significant difference in the lives of the patient and owner.
- Parker VJ. Chronic kidney disease screening and confirmation testing in cats. Todays Vet Pract. 2018;Sep/Oct:9-12.
- Polzin DJ, Churchill JA. Renal diets are indicated for cats with International Society Chronic Kidney Disease stage 2 to 4. The pro view. Vet Clin Small Anim Pract 2016;46(6):1049-1065.
- Freeman L, Becvarova I, Cave N, et al. WSAVA nutritional assessment guidelines. J Small Anim Pract 2011;52(7):385-396.
- Laflamme DP, Hannah SS. Discrepancy between use of lean body mass or Nitrogen balance to determine protein requirements for adult cats. J Fel Med Surg 2013;15:691-697.
- Laflamme DP. Lean body mass as affected by aging and protein intake in geriatric cats. Proceedings of the 17th European Society of Veterinary and Comparative Nutrition Congress; Ghent, Belgium; September 19-21, 2013. Page 50.
- Kuwahara Y, Ohba Y, Kitoh K, et al. Association of laboratory data and death within one month in cats with chronic renal failure. J Small Anim Pract 2006;47(8):446-450.
- Chakrabarti S, Syme HM, Elliott J. Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease. J Vet Intern Med 2012;26(2):275-281.
- Brown SA, Brown CA, Crowell WA, et al. Dietary fatty acid composition affects renal function. Proceedings of the Purina Forum on Small Animal Nutrition 1996. Abstract P. 35.
- Yu S, Paetau-Robinson I. Dietary supplements of vitamins E and C and beta-carotene reduce oxidative stress in cats with renal insufficiency. Vet Res Commun 2006;30(4):403-413.
- Freeman L, Lachaud MP, Matthews S, et al. Evaluation of weight loss over time in cats with chronic kidney disease. J Vet Intern Med 2016;30(5):1661.
- Quimby J, Lunn KF. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial. Vet J 2013;197(3):651-655.
Sparkes AM, Caney S, Chalhoub S, et al. ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease. J Feline Med Surg 2016;18:219-239.